Abstract The endocannabinoid 2-arachidonoylglycerol (2-AG) has been reported to exhibit
anticancer effects, including against colorectal cancer (CRC); however, the detailed …

Background The endocannabinoid (eCB) 2-arachidonoylglycerol (2-AG) is a known
modulator of inflammation and ligand to both, pro-inflammatory cannabinoid receptor 1 …

Recently, an interesting study entitled “2-Arachidonoylglycerol Attenuates Myocardial
Fibrosis in Diabetic Mice Via the TGF-β1/Smad Pathway” was published in Cardiovascular …

Colorectal cancer is one of the leading causes of death in Western countries; therefore, the
implementation of healthy dietary habits in order to prevent its occurrence is a desirable …

Background The endocannabinoids, anandamide (AEA) and 2‐arachidonoyl glycerol (2‐
AG), are considered promising potential anticancer agents. In this study, we examined the …

Endocannabinoids (ECs), anandamide (AEA) and 2-arachidonoylglycerol (2-AG), inhibit
proliferation of carcinoma cells. Several enzymes hydrolyze ECs to reduce endogenous EC …

Cyclooxygenase-2 (COX-2) is an enzyme that plays a key role in inflammatory processes.
Classically, this enzyme is upregulated in inflammatory situations and is responsible for the …

Abstract Endogenous 2‐arachidonoylglycerol (2‐AG) is antiinvasive in androgen‐
independent prostate carcinoma (PC‐3) cells. Invasion of PC‐3 cells is also inhibited by …

Background Endocannabinoids have recently drawn attention as promising anti-cancer
agents. We previously observed that anandamide (AEA), one of the representative …

Accumulating evidence suggests that diets rich in ω-3 polyunsaturated fatty acids (PUFAs)
offer protection against vascular inflammation, neuroinflammation, hypertension, and …